Aspira Women's Health
In Brief This Week: Genomate Health, Aspira Women’s Health, U of Adelaide, Illumina, Asklepios
News items for the week of Nov. 4, 2024.
Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split
Aspira Women's Health has been evaluating Dana-Farber's microRNA technology for ovarian cancer detection since early 2021.
In Brief This Week: Aspira Women's Health, Sprinter Health, Naveris, Sophia Genetics, Theseus, Syros
News items for the week of Jan. 31, 2022.
Aspira Women's Health Preliminary Q4 OVA1 Sales up 23 Percent; Firm Details Pipeline Progess
The company also announced a five-year deal with healthcare group Axia Women's Health to provide in-house genetic carrier screening.